Prevalence of the Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians

Experimental and Molecular Pathology

Volumn 79, Issue 1, 2005, Pages 9-13

  Angeline, T ^a   Bentley, Heather A ^b   Hawk, Arnold B ^b   Manners, Richard J ^c   Mokashi, Harsha A ^c   Jeyaraj, Nirmala ^a   Tsongalis, Gregory J ^b  

^a LADY DOAK COLLEGE   (India)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c Roche Diagnostics Corporation   (United States)

Author keywords

Factor V G1691A; Single nucleotide polymorphisms; Tamilians

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; PROTHROMBIN;

ARTICLE; CONTROLLED STUDY; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDIA; MEDICAL INSTRUMENTATION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA MUTATIONAL ANALYSIS; FACTOR V; HUMANS; INDIA; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTHROMBIN; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 22144472522     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.03.003     Document Type: Article

References (28)

1. N.J. Beauchamp, M.E. Daly, K.K. Hampton, P.C. Cooper, and E. Preston High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis Hypertension 88 1994 219 222
2. R.M. Bertina, B.P.C. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, H. de Ronde, P.A. van der Velden, and P.H. Reitsma Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
3. L.D. Cripe, K.D. Moore, and W.H. Kane Structure of the gene for human coagulation factor V Biochemistry 31 1992 3777 3785
4. S.J.F. Degen, and E.W. Davie Nucleotide sequence of the gene for human prothrombin Biochemistry 26 1987 6165
5. M.P. de Maat, E.M. Bladbjerg, L.G. Johansen, J. Gram, and J. Jespersen Absence of prothrombin mutation in Inuit (Greenland Eskimos) Thromb. Haemostasis 79 1998 882
6. C.J. Doggen, V.M. Cats, R.M. Bertina, and F. Rosendaal Interaction of coagulation defects and cardiovascular risk factors increased risk of myocardial infarction associated with factor V leiden or prothrombin 20210A Circulation 97 1998 1037 1041
7. J. Flint, R.M. Harding, J.B. Clegg, and A.J. Boyce Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants Hum. Genet. 91 1993 91 117
8. R.F. Franco, S.E.B. Santos, J. Elion, M.H. Tavella, and M.A. Zago Prevalence of the G20210A polymorphism in the 3′-untranslated region of the prothrombin gene in different human populations Acta Haematol. 100 1998 9 12
9. J.H. Griffin, B. Evatt, C. Wideman, and J.A. Fernandez Anticoagulant protein C pathway defective in majority of thrombophilic patients Blood 82 1993 1989 1993
10. D. Helley, C. Besmond, R. Ducrocq, F. da Silva, M.C. Guillin, A. Bezeaud, and J. Elion Polymorphism in exon 10 of the human coagulation factor V gene in a population at risk for sickle cell disease Hum. Genet. 100 1996 245 248
11. S.H. Hong Genotype distribution of the mutations in the coagulation factor V gene in the Korean population: absence of its association with coronary artery disease Korean J. Biol. Sci. 7 2003 255 259
12. T.E. Howard, M. Marusa, and J. Boisza The prothrombin gene 3′-untranslated region is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency Blood 91 1998 1092
13. F. Ishida, T. Ito, N. Ichikawa, S. Shimodaira, O. Takamiya, K. Furihata, K. Kiyosawa, and K. Kitano Arg 506 Gln factor V mutation is uncommon in eastern Asian populations Blood 86 1995 917a
14. R.J. Jenny, D.D. Pittman, J.J. Toole, R.W. Kriz, R.A. Aldape, R.M. Hewick, R.J. Kaufman, and K.G. Mann Complete cDNA and derived amino acid sequence of human factor V Proc. Natl. Acad. Sci. U. S. A. 84 1987 4846 4850
15. H.P. Kohler, M. Boothby, L. McCormack, W.C. Knowler, and P.J. Grant Incidence of Arg506 Gln mutation (factor V Leiden) in Pima Indians Thromb. Haemostasis 78 1997 961 962
16. X.Y. Liu, D. Nelson, C. Grant, V. Morthland, S.H. Goodnight, and R.D. Press Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C Diagn. Mol. Pathol. 4 1995 191 197
17. H. Mandel, B. Brenner, M. Berant, N. Rosenberg, N. Lanir, C. Jakobs, B. Fowler, and U. Seligsohn Coexistence of hereditary homocystinuria and factor v leiden-effect on thrombosis N. Engl. J. Med. 334 1996 763 768
18. G. Pepe, O. Rickards, O.C. Vanegas, T. Brunelli, A.M. Gori, B. Giusti, M. Attanasio, D. Prisco, G.F. Gensini, and R. Abbate Prevalence of factor V Leiden mutation in Non-European populations Thromb. Haemostasis 77 1997 329 331
19. S.R. Poort, F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
20. D.C. Rees, M. Cox, and J.B. Clegg World distribution of factor V Leiden Lancet 346 1995 1133 1134
21. F.R. Rosendaal, T. Koster, J.P. Vandenbroucke, and P.H. Reitsma High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
22. F.R. Rosendaal, D.S. Siscovick, S.M. Schwartz, B.M. Psaty, T.E. Raghunathan, and H.L. Vos A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women Blood 90 1997 1747 1750
23. N.J. Royle, D.M. Irwin, M.L. Koschinsky, R.T.A. MacGillivray, and J.L. Hamerton Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively Somatic Cell Mol. Genet. 13 1987 285
24. M. Samaha, M. Trossaert, J. Conrad, M.H. Horellou, I. Elalamy, and M.M. Samama Prevalence and patient profile in activated protein C resistance Am. J. Clin. Pathol. 104 1995 450 454
25. U. Seligsohn, and A. Lubetsky Genetic susceptibility to venous thrombosis N. Engl. J. Med. 344 2001 1222 1231
26. O. Takamiya, F. Ishida, and H. Kodaira APC-resistance and MnlI genotype (Gln 506) of coagulation factor V are rare in Japanese population [letter] Thromb. Haemostasis 74 1995 996
27. C.J. van Rooden, F.R. Rosendaal, A.E. Meinders, J.A. Van oostayen, F.J.M. vander Meer, and M.V. Huisman The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis Haematologica 89 2004 201 206 (B S T R A C T)
28. H. Wang, D.C. Ridell, E.R. Guinto, R.T.A. MacGillivray, and J.L. Hamerton Localization of the gene encoding human factor V to chromosome 1q21-25 Genomics 2 1988 234 238